NeuroSense Therapeutics Revenue and Competitors
Employee Data
- NeuroSense Therapeutics has 28 Employees.
- NeuroSense Therapeutics grew their employee count by 0% last year.
NeuroSense Therapeutics's People
| Name | Title | Email/Phone |
|---|
NeuroSense Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | N/A | 11 | 10% | N/A | N/A |
#10 | $5.4M | 35 | 3% | N/A | N/A |
What Is NeuroSense Therapeutics?
Advancing research, development and therapy for ALS and additional CNS indications.\n\nNeuroSense Therapeutics Ltd. (NASDAQ: NRSN) is a clinical stage Biotech company focusing on the development of a ground-breaking treatment for ALS patients, as well as other neurodegenerative diseases.\n\nCurrently in conducting a Phase 2b, double-blind, randomized, placebo controlled clinical study in ALS patients globally.\n$NRSN
keywords:N/A
N/A
Total Funding
28
Number of Employees
N/A
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $4.3M | 28 | 8% | N/A |
#2 | $2.8M | 28 | N/A | N/A |
#3 | $4M | 28 | N/A | N/A |
#4 | $2.7M | 28 | N/A | N/A |
#5 | $2.8M | 28 | N/A | N/A |